amsterdam : DSM

September 07, 2011 02:20 ET

DSM announces repurchase of shares to cover existing option plans

HEERLEN, NETHERLANDS--(Marketwire - Sep 7, 2011) -

Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it intends to repurchase 4,000,000 ordinary shares, starting on 7 September 2011, in order to cover its commitments under existing management and personnel option plans. Based on the closing price of the DSM share on NYSE Euronext on 6 September 2011 this would be equivalent to approximately EUR 126 million.

DSM has signed a Discretionary Management Agreement with the bank that will execute the repurchase. The repurchase price will be based on the daily VWAP (Volume Weighted Average Price). Volumes to be repurchased will on average be 10% of the daily trading volume on Euronext Amsterdam, within a bandwidth of 7-13% per day.

In accordance with the present regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases.

DSM - Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about EUR 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com

Press release-pdf: http://hugin.info/130663/R/1544570/473406.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE


Contact Information

  • For more information:

    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    fax +31 (0) 45 5740680
    e-mail Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 10 4590275
    e-mail Email Contact